Data as of Nov 4, 2026.
FMED vs XDAT: Holdings Overlap & Returns
Over the year to Nov 4, 2026, FMED returned +27.4% to XDAT's −11.5%; 0% of their weight is in the same names.
askIQ about this page
askIQ about FMED and XDATNet assets: $52m on Sep 30, 2026 for Fidelity Disruptive Medicine ETF, and $3.7m on Nov 3, 2026 for Franklin Exponential Data ETF.
22% of FMED's weight is in S&P 500 companies and 78% is outside the index. Holdings as of Aug 31, 2026.
60% of XDAT's weight is in S&P 500 companies and 40% is outside the index. Holdings as of Jun 30, 2026.
Pair scorecard
Both cost 0.50% a year; their one-year returns differ by 38.9 points.
Points (pts) are percentage points.
| Measure | FMED | XDAT |
|---|---|---|
| Return | ||
| Total return, 1 year | +27.4% | −11.5% |
| Drawdown | ||
| Below its all-time high | 21.1%, high on Nov 9, 2021 | |
| Against its benchmark | ||
| What it tracks | Broad innovation and megatrends | Broad innovation and megatrends |
| Its benchmark, total return, 1 year | +14.8% | |
| Against its benchmark, 1 year | behind by 26.3 pts | |
| Cost and size | ||
| Expense ratio | 0.50% | 0.50% |
| Net assets, FMED as of Sep 30, 2026 and XDAT as of Nov 3, 2026 | $52m | $3.7m |
| Holdings | ||
| Holdings in common | 0% | |
What they share
By the books each fund has filed, FMED and XDAT hold 0% of their money in the same securities at the same weight. Holdings dated Jun 30, 2026 and Aug 31, 2026.
half
0% in common
Only in one fund ↓
Window by window
| Total return | vs its benchmark | |||
|---|---|---|---|---|
| Window | FMED | XDAT | FMED | XDAT |
| 3 months | +14.9% | −7.7% | not measured | −7.4 pts vs IWV |
| 6 months | +31.2% | +2.1% | not measured | −2.8 pts vs IWV |
| 1 year | +27.4% | −11.5% | not measured | −26.3 pts vs IWV |
| 3 years | +57.8% | +33.3% | not measured | −47.7 pts vs IWV |
| Since launchNot the same days: FMED Jun 2023 · XDAT Jan 2021 | +31.7% | −1.8% | not measured | −106.1 pts vs IWV |
Side by side
As of Nov 4, 2026. Source: ETFIQ.
0% of the two portfolios are the same securities at the same weight.
FMED
By weight, 22% of FMED's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 33% of the fund across 72 positions, as filed for Aug 31, 2026. Over the year to Nov 4, 2026 the fund returned +27.4% with distributions reinvested.
Over the year to Nov 4, 2026 the fund returned −11.5% with distributions reinvested against +14.8% for its benchmark, the Russell 3000 Index, so a holder was behind by 26.3 pts.
By weight, 60% of XDAT's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 86%. The top ten holdings are 56% of the fund across 59 positions, as filed for Jun 30, 2026. It sits 21.1% below its all-time high of Nov 9, 2021.
Questions people ask
- Do FMED and XDAT hold the same stocks?
- By their latest filings, 0% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Links are sources, not endorsements. A comparison is not a recommendation.
How this is computed
Overlap adds up the smaller of the two weights for each security both funds hold.
Every number is an ETFIQ calculation with distributions reinvested.
Cite this pageCitation, APA and Markdown
ETFIQ, FMED against XDAT, data as of Nov 4, 2026. https://etfiq.com/compare/themes/fmed-vs-xdat
ETFIQ. (Nov 4, 2026). FMED against XDAT. Retrieved from https://etfiq.com/compare/themes/fmed-vs-xdat
[FMED against XDAT (ETFIQ, Nov 4, 2026)](https://etfiq.com/compare/themes/fmed-vs-xdat)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.